This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Influenza A Virus H10 Subtype Haemagglutinin (HA) Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for influenza a virus H10 subtype haemagglutinin. It is affinity purified by protein A. It can be applied to ELISA, IFA, FACS, WB and HI assays of influenza a virus H10 subtype haemagglutinin.
Specifications
Target Information
The influenza A virus H10 subtype hemagglutinin (HA) is a critical surface glycoprotein that is essential for the virus's infectivity. The HA protein enables the virus to bind to sialic acid receptors on host cells, initiating the process of viral entry. Following binding, the HA undergoes a conformational change that triggers membrane fusion, allowing the release of the viral genome into the host cell. As a target for antiviral strategies, the H10 subtype HA is significant due to its role in host-cell recognition and fusion. The HA protein is a primary antigen that induces the production of neutralizing antibodies, making it a component of vaccines designed to protect against influenza infection. Inhibiting the HA function could prevent the virus from entering host cells, thus limiting the spread of the infection.
Shipping and Storage
This product is shipped with wet ice packs. Store at -20°C on receipt (up to 24 months). Avoid exposure to light. Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
References
- Gultyaev, Alexander P., et al. "Subtype-specific structural constraints in the evolution of influenza A virus hemagglutinin genes." Scientific Reports 6.1 (2016): 38892.